The Global Avonex Market size is projected to reach USD 3,854.6 Million by 2028 from USD 1,516.1 Million in 2018, growing at a CAGR of 12.4% during the forecast period (2021-2028). The rising incidence of multiple sclerosis (MS) and increasing prevalence of chronic diseases will be the key factors driving growth during the forecast period.
Avonex is a medicine that slows the progression of multiple sclerosis (MS). Avonex works by modifying immune responses to reduce inflammation. It belongs to a family of medicines called interferons, which are natural proteins made in our bodies that help fight off viruses or infections. Interferon beta-lactamase has no direct antiviral effect on the virus causing MS.
On the basis of Types, the market is segmented into Prefilled Syringe, Powder Form.
A prefilled syringe is a type of injection in which the medication has already been measured and prepared. The injectable drug is mixed with water or another liquid to form a suspension, then withdrawn into an empty needleless container called a vial. A plunger on the vial acts as a stopper that can be pushed down when it's time for administration so as not to lose space in preparation for filling again.
Avonex in Powder Form is the powder form of the same medicine and is indicated for injection into a muscle (intramuscular). It contains 50mg of Interferon beta-Ia, which belongs to a class of drugs called immunomodulators. The active ingredient interferes with how immune system cells produce proteins that cause inflammation or interfere with normal cell function.
On the basis of Application, the market is segmented into Hospitals, Drugs Stores, and Others.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Latin America holds a significant share in the Global Avonex market with more than 27% revenue contribution during 2021-2028 through its wide application in hospitals as well as drugs stores for autoimmune disorder treatment along with other emerging markets like the Asia Pacific region that have high potential to grow.
The factors driving this growth are the increasing prevalence of chronic autoimmune diseases and growing awareness about immunomodulatory drugs among physicians globally. However, the high prices for such medicines coupled with their limited usage patterns may pose challenges to further expansion in emerging markets where healthcare spending remains low and access barriers persist due to socioeconomic disparities or insufficient infrastructure facilities.
Up Market Research published a new report titled “Avonex Market research report which is segmented by Types (Prefilled Syringe, Powder Form), By Applications (Hospital, Drugs Store, Other), By Players/Companies Biogen”.
Report Attributes | Report Details |
Report Title | Avonex Market Research Report |
By Type | Prefilled Syringe, Powder Form |
By Application | Hospital, Drugs Store, Other |
By Companies | Biogen |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 225 |
Number of Tables & Figures | 158 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Prefilled Syringe, Powder Form and By Application Hospital, Drugs Store, Other.
Some of the companies that are profiled in this report are:
Avonex Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Avonex Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Avonex Market Report:
Some other reports from this category!